Menu
Back to User profile » Professor Ammar Almaaytah
Papers published by Professor Ammar Almaaytah:
Budget Impact Analysis of Switching to Rituximab’s Biosimilar in Rheumatology and Cancer in 13 Countries Within the Middle East and North Africa
Almaaytah A
ClinicoEconomics and Outcomes Research 2020, 12:527-534
Published Date: 15 September 2020
Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae
Swedan S, Shubair Z, Almaaytah A
Infection and Drug Resistance 2019, 12:2019-2030
Published Date: 9 July 2019
The evaluation of the synergistic antimicrobial and antibiofilm activity of AamAP1-Lysine with conventional antibiotics against representative resistant strains of both Gram-positive and Gram-negative bacteria
Almaaytah A, Abualhaijaa A, Alqudah O
Infection and Drug Resistance 2019, 12:1371-1380
Published Date: 23 May 2019
Design and characterization of a new hybrid peptide from LL-37 and BMAP-27
Al Tall Y, Abualhaijaa A, Alsaggar M, Almaaytah A, Masadeh M, Alzoubi KH
Infection and Drug Resistance 2019, 12:1035-1045
Published Date: 30 April 2019
In vivo antimicrobial activity of the hybrid peptide H4: a follow-up study
Almaaytah A, Albalas Q, Alzoubi KH
Infection and Drug Resistance 2018, 11:1383-1386
Published Date: 3 September 2018
Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides
Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH
Infection and Drug Resistance 2018, 11:835-847
Published Date: 1 June 2018
Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria
Almaaytah A, Mohammed GK, Abualhaijaa A, Al-Balas Q
Drug Design, Development and Therapy 2017, 11:3159-3170
Published Date: 3 November 2017
Peptide consensus sequence determination for the enhancement of the antimicrobial activity and selectivity of antimicrobial peptides
Almaaytah A, Ajingi Y, Abualhaijaa A, Tarazi S, Alshar’i N, Al-Balas Q
Infection and Drug Resistance 2017, 10:1-17
Published Date: 29 December 2016
Novel glyoxalase-I inhibitors possessing a “zinc-binding feature” as potential anticancer agents
Al-Balas QA, Hassan MA, Al-Shar’i NA, Mhaidat NM, Almaaytah AM, Al-Mahasneh FM, Isawi IH
Drug Design, Development and Therapy 2016, 10:2623-2629
Published Date: 17 August 2016
Dispensing of non-prescribed antibiotics in Jordan
Almaaytah A, Mukattash TL, Hajaj J
Patient Preference and Adherence 2015, 9:1389-1395
Published Date: 30 September 2015
Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme
Al-Balas QA, Sowaileh MF, Hassan MA, Qandil AM, Alzoubi KH, Mhaidat NM, Almaaytah AM, Khabour OF
Drug Design, Development and Therapy 2014, 8:129-163
Published Date: 16 January 2014